MHRA grants conditional marketing authorisation1 for COVID-19 treatment Xevudy (sotrovimab)
GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional marketing authorisation for…
Read More...
Read More...
